Settings
Save and close
For more than 90 years, research at JAX has expanded knowledge of mammalian genetics and contributed to medical progress. Now, at its Bar Harbor, Maine, and Farmington, Connecticut, research campuses, JAX is poised to bridge the gaps between biological knowledge and medical progress. With unmatched model organism research expertise and resources and modern research methods and tools in hand, JAX scientists are accelerating both basic discovery and clinical translation for patient benefit.
Researchers at JAX contribute to a highly impactful, multi-disciplinary biomedical research program focusing on mammalian genetics and human genomics. Faculty, trainees and laboratory staff benefit from collaborative intra-institutional science, a broad scope for faculty inquiry, robust scientific resources and advanced technologies, and extensive support services. The unique environment catalyzes discovery and insights across the spectrum of basic, translational and preclinical research.
Comprehensive sponsored research support yields high grant application success rates and thorough grant management.
Advanced equipment and deep expertise expand research possibilities.
Professional support is provided to faculty for day-to-day tasks as well as specialized ventures.
Lon Cardon
Ph.D., FMedSci
President and CEO
Responsible for the Laboratory’s global vision, strategic direction, research and operations
Mary Dickinson
Ph.D.
Executive Vice President and Chief Scientific Officer
Mary Dickinson, Ph.D. is the executive vice president and chief scientific officer at The Jackson Laboratory (JAX). She leads JAX’s research enterprise, overseeing scientific strategy and operations to build on JAX’s unique strengths in genetics and genomics. She is responsible for recruiting and retaining faculty, overseeing and seeding new initiatives and collaborations, and planning and executing the research capital budget.
Mark Adams
Ph.D.
Professor & Interim Scientific Director, The Jackson Laboratory for Genomic Medicine
Leads the research and clinical genome sequencing groups.
Nadia Rosenthal
Ph.D., FMedSci, FAAHMS
Scientific Director and Professor, The Jackson Laboratory for Mammalian Genetics, the Maxine Groffsky Endowed Chair
Investigates the role of genetic variation and the immune system in tissue repair, focusing on cardiovascular and skeletal muscle disease
Andy Greene
Ph.D.
Senior Vice President of Research and Professor
Studies the role of progenitor cells in cardiovascular remodeling. Develops tools for research in Protein Science.
Charlie Wray
Ph.D.
Vice President for Education
Provides direction and strategic leadership for training programs for undergraduates, graduate students, post-doctoral fellows at JAX and for educational offerings for young scientists, teachers, professors and healthcare professionals.
I was attracted by how diverse the research programs are at JAX, beyond just cancer. I think it’s great to benefit from researchers with diverse expertise and backgrounds.
– Assistant Professor Eric Wang, Ph.D., leukemia researcher
Endometriosis research at JAX is improving the lives of those impacted by the disease – from seeking to develop early detection with genetic testing to understanding the development of the condition at a single cell level.
View more
Combining genetic therapy and bone marrow transplantation may offer comprehensive treatment solution for multiple sulfatase deficiency.
View more